OX40 and CD30 signals in CD4+ T-cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4+ T-cell memory but not effector function-Reference-Cited by-同舟云学术

OX40 and CD30 signals in CD4+ T-cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4+ T-cell memory but not effector function

Published:2011-10-21 Issue:1 Volume:244 Page:134-148
ISSN:0105-2896
Container-title:Immunological Reviews
language:en
Short-container-title:

Author:

Withers David R.,Gaspal Fabrina M.,Bekiaris Vasileios,McConnell Fiona M.,Kim MiYeon,Anderson Graham,Lane Peter J.L.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-065X.2011.01057.x/fullpdf

Reference96 articles.

1. Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens;Liu;Eur J Immunol,1991

2. CD4(+)CD3(−) accessory cells costimulate primed CD4 T cells through OX40 and CD30 at sites where T cells collaborate with B cells;Kim;Immunity,2003

3. Two sides of a cellular coin: CD4(+)CD3− cells regulate memory responses and lymph-node organization;Lane;Nat Rev Immunol,2005

4. Organogenesis of lymphoid tissues;Mebius;Nat Rev Immunol,2003

5. Requirement for RORgamma in thymocyte survival and lymphoid organ development;Sun;Science,2000

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of innate lymphoid cells in systemic lupus erythematosus;Cytokine;2024-07

2. Soluble Plasma Proteins of Tumor Necrosis Factor and Immunoglobulin Superfamilies Reveal New Insights into Immune Regulation in People with HIV and Opioid Use Disorder;Vaccines;2024-05-09

3. The crosstalk between ILC3s and adaptive immunity in diseases;The FEBS Journal;2023-12-08

4. The interaction network between group 3 innate lymphoid cells and other cells;Fundamental Research;2023-12

5. mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy;Cancers;2023-09-04